Reports from the conference

Introduction

In this issue we continue reports from this European conference that is held every two years.

This year a comprehensive programme of lectures and sessions available as webcasts and podcasts and include many of the slide sets:

http://www.europeanaidsclinicalsociety.org

http://www.multiwebcast.com/eacs/2009/12th

Access requires a free one-time registration using the invitation code: EACS2009

It is disappointing that the abstracts from the meeting were not available online (as we went to press), and are only available as a subscription issue of HIV Medicine (2009, volume 10, issue S2).

The following reports are included in this issue.

• Screening for anal cancer recommended for HIV-positive men

• Once-daily darunavir/r monotherapy is suboptimal as initial regimen in treatment-naïve people

• Central fat accumulation remains a significant problem in patients starting HAART after 2005 with higher incidence in women compared to men

• Alendronate improves bone mineral density in HIV-positive people with osteoporosis at 96 weeks

• TMC278 did not show teratogenic potential in animal models

• Etravirine pregnancy data from five cases: no dose adjustment required

• No clinically relevant interactions between TMC278 and oral contraceptives (norethindrone plus ethinylestradiol)

• Gender-based differences in patients receiving antiretroviral therapy

• Pilot PK study of two generic paediatric formulations of lopinavir/ritonavir vs originator products

• Other selected PK and drug interaction summaries from EACS